“Extensive evidence from clinical trials shows that the collaborative care model can almost double the rates of exposure to evidence-based depression/anxiety treatments as well as markedly improve clinical outcomes for patients with depression and anxiety,” Katon said. “More recent evidence also suggests that many people with depression have comorbid medical illnesses. In a 2010 trial, we aimed to improve care for depression and poorly controlled diabetes and/or heart disease with a multicondition collaborative care model. It improved not only the patients’ depression-related outcomes, but also improved blood glucose, systolic blood pressure, and LDL cholesterol and reduced overall medical costs.”
Look for a special series of articles on integrated care to begin in Psychiatric News in July. For other news about collaborative care, see Psychiatric News here. Also see an Open Forum in Psychiatric Services on this topic here.